About Oculocutaneous albinism type 2
Oculocutaneous albinism type 2 is a rare disease catalogued by Orphanet (ORPHA:79432). It is associated with the OCA2, MC1R genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Oculocutaneous albinism type 2 trials.
Search ClinicalTrials.gov for "Oculocutaneous albinism type 2" or filter by Orphanet code ORPHA:79432 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Oculocutaneous albinism type 2 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Oculocutaneous albinism type 2. Updated daily.